ECSP20016817A - Sistemas y métodos para el control de la enfermedad de necrosis hepatopancreática aguda - Google Patents

Sistemas y métodos para el control de la enfermedad de necrosis hepatopancreática aguda

Info

Publication number
ECSP20016817A
ECSP20016817A ECSENADI202016817A ECDI202016817A ECSP20016817A EC SP20016817 A ECSP20016817 A EC SP20016817A EC SENADI202016817 A ECSENADI202016817 A EC SENADI202016817A EC DI202016817 A ECDI202016817 A EC DI202016817A EC SP20016817 A ECSP20016817 A EC SP20016817A
Authority
EC
Ecuador
Prior art keywords
systems
methods
control
necrosis disease
hepatopancreatic necrosis
Prior art date
Application number
ECSENADI202016817A
Other languages
English (en)
Inventor
Elena Sineva
Sayre Richard
Tatiana Vinogradova-Shah
Original Assignee
Pebble Labs Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2018/025766 external-priority patent/WO2018184029A1/en
Priority claimed from PCT/US2018/033976 external-priority patent/WO2018217819A1/en
Application filed by Pebble Labs Usa Inc filed Critical Pebble Labs Usa Inc
Publication of ECSP20016817A publication Critical patent/ECSP20016817A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/60—Isolated nucleic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Dentistry (AREA)
  • Virology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Immunology (AREA)
  • Agronomy & Crop Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Physiology (AREA)
  • Birds (AREA)
  • Insects & Arthropods (AREA)
  • Oncology (AREA)

Abstract

En general, la tecnología de la invención se refiere a novedosas estrategias para el control de enfermedades en sistemas animales. Específicamente, la tecnología de la invención se refiere a métodos, sistemas y composiciones novedosas para el biocontrol de patógenos en sistemas acuáticos. Específicamente, la invención puede comprender técnicas, sistemas y métodos novedosos para el biocontrol de patógenos transmisores de enfermedades que afectan a los camarones en los sistemas acuícolas.
ECSENADI202016817A 2017-08-07 2020-03-06 Sistemas y métodos para el control de la enfermedad de necrosis hepatopancreática aguda ECSP20016817A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762541824P 2017-08-07 2017-08-07
PCT/US2018/025766 WO2018184029A1 (en) 2017-03-31 2018-04-02 Novel system for the biocontrol of pathogens in aquaculture and other animal systems
PCT/US2018/033976 WO2018217819A1 (en) 2017-05-22 2018-05-22 Transbiotic regulation of bacterial gene expression

Publications (1)

Publication Number Publication Date
ECSP20016817A true ECSP20016817A (es) 2020-04-22

Family

ID=65271567

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202016817A ECSP20016817A (es) 2017-08-07 2020-03-06 Sistemas y métodos para el control de la enfermedad de necrosis hepatopancreática aguda

Country Status (9)

Country Link
US (1) US11944676B2 (es)
EP (1) EP3664616A4 (es)
CN (1) CN111433349A (es)
BR (1) BR112020002689A2 (es)
CL (1) CL2020000329A1 (es)
EC (1) ECSP20016817A (es)
MX (1) MX2020001574A (es)
SG (1) SG11202001143YA (es)
WO (1) WO2019032629A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11944676B2 (en) 2017-08-07 2024-04-02 Pebble Labs Inc. Systems and methods for the control of acute hepatopancreatic necrosis disease
CN110317792B (zh) * 2019-06-03 2021-05-25 台州学院 副溶血弧菌噬菌体vp-hyp2及其应用
CN114980750A (zh) * 2019-09-05 2022-08-30 美国卵石实验室公司 用于抑制细菌毒素以治疗水生动物早期死亡综合征的系统、方法和组合物
WO2021252927A1 (en) * 2020-06-12 2021-12-16 Pebble Labs Inc. Novel probiotic bacteria and methods to control pathogens in aquatic animals
CN112753629B (zh) * 2020-12-30 2022-08-30 亚太海洋生物科技(厦门)有限公司 南美白对虾养殖前期去除急性肝胰腺坏死病毒的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294533A (en) 1988-07-05 1994-03-15 Baylor College Of Medicine Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria
WO2003064592A2 (en) * 2001-10-26 2003-08-07 Quorex Pharmaceuticals, Inc. Inhibitors of autoinducer transporters
US20050227933A1 (en) 2001-11-29 2005-10-13 Benkovic Stephen J Treatment of bacterial induced diseases using DNA methyl transferase inhibitors
US8633028B2 (en) * 2003-07-02 2014-01-21 Musc Foundation For Research Development dsRNA induced specific and non-specific immunity in crustaceans and other invertebrates and biodelivery vehicles for use therein
US7247437B2 (en) 2003-08-21 2007-07-24 Trustees Of Tufts College Vibrionaceae replication factors and methods of use thereof
US20050158326A1 (en) 2003-12-24 2005-07-21 Chin-Yu Chen Compositions for reducing virus infection rate in aquatic crustaceans and applications thereof
AU2005213981A1 (en) 2004-02-06 2005-09-01 Advanced Bionutrition Corporation RNA-mediated interference to control disease in terrestrial and aquaculture animals
US20080107652A1 (en) * 2006-08-25 2008-05-08 Science & Technology Corporation @ University Of New Mexico Stc.Unm Methods and compositions for control of disease in aquaculture
CN107047934A (zh) 2008-09-17 2017-08-18 拜尔作物科学有限合伙公司 利用枯草芽孢杆菌菌株以增强动物健康的方法
US8828961B2 (en) 2010-10-27 2014-09-09 Harrisvaccines Methods and compositions to protect aquatic invertebrates from disease
KR101242821B1 (ko) * 2011-01-31 2013-03-12 씨제이제일제당 (주) 비브리오 속 미생물에 대한 생물학적 방제용 프로바이오틱스
KR101049672B1 (ko) 2011-02-01 2011-07-14 박명진 초음파 유도하 중재적 시술용 바늘구조
GB201107768D0 (en) * 2011-05-10 2011-06-22 Univ Manchester Riboswitches
US9932598B2 (en) * 2012-08-02 2018-04-03 The Regents Of The University Of California Metabolic engineering of microbial organisms
BR112015023424A2 (pt) 2013-03-15 2017-11-28 Monsanto Technology Llc construto de expressão engenheirado, método para aprimoramento de produção de rna ou proteína, vetor, célula, hospedeira bacteriana, sistema de cultura de célula para síntese in vivo de dsrna, composição e método para controlar uma infestação de pragas de invertebrados ou para inibir a propagação de uma doença viral em uma população de plantas, e terminador transcricional
WO2015059690A1 (en) * 2013-10-24 2015-04-30 Yeda Research And Development Co. Ltd. Polynucleotides encoding brex system polypeptides and methods of using s ame
US20150125545A1 (en) * 2013-11-04 2015-05-07 Aardvark Ip Holding, Llc Aquaculture water treatment systems and methods
EP3512951A4 (en) 2016-09-16 2020-07-08 Pebble Labs USA Inc. INNOVATIVE PARATRANSGENIC SYSTEM FOR THE BIOLOGICAL CONTROL OF DISEASE-RELATING MOSCITOS
WO2018184029A1 (en) 2017-03-31 2018-10-04 Pebble Labs, Inc. Novel system for the biocontrol of pathogens in aquaculture and other animal systems
CA3067988A1 (en) 2017-05-22 2018-11-29 Pebble Labs Usa Inc. Transbiotic regulation of bacterial gene expression
US11944676B2 (en) 2017-08-07 2024-04-02 Pebble Labs Inc. Systems and methods for the control of acute hepatopancreatic necrosis disease

Also Published As

Publication number Publication date
US11944676B2 (en) 2024-04-02
EP3664616A4 (en) 2021-08-11
BR112020002689A2 (pt) 2020-08-25
SG11202001143YA (en) 2020-03-30
WO2019032629A1 (en) 2019-02-14
EP3664616A1 (en) 2020-06-17
CL2020000329A1 (es) 2020-08-14
MX2020001574A (es) 2020-09-03
US20200178566A1 (en) 2020-06-11
CN111433349A (zh) 2020-07-17

Similar Documents

Publication Publication Date Title
ECSP20016817A (es) Sistemas y métodos para el control de la enfermedad de necrosis hepatopancreática aguda
CL2020001797A1 (es) Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas.
CL2018000052A1 (es) Heterociclos nitrogenados como pesticidas.
UY36063A (es) “nuevos compuestos sustituidos con halógeno”
BR112017005388A2 (pt) método para criar animais.
CO2018001840A2 (es) Composiciones biofarmacéuticas que comprenden anticuerpos anti-il-5
BR112019025372A2 (pt) Suplemento de ração animal, composição de ração animal, usos de um suplemento, métodos para produzir um suplemento de ração animal e para produzir uma composição de ração animal
BR112019000693A2 (pt) composições de muc1- car e métodos para uso
ECSP19057403A (es) Usos terapéuticos de un polvo de insectos
WO2015184311A3 (en) Method of feeding an animal
BR112013005136A2 (pt) composições e métodos para controlar pragas de nematodeo
CL2018002645A1 (es) Sulfonamidas sustituidas para controlar plagas animales
CR11810A (es) Compuestos de 1,2-benzotiazolo utiles para combatir plagas animales
BR112018006866A2 (pt) compostos agonistas de ppar, composições farmacêuticas e métodos de uso dos mesmos
EA201891342A1 (ru) Изоиндольные соединения
ZA201901168B (en) Novel compounds for treating parasitic disease
CL2018000433A1 (es) Procedimientos para mejorar la salud de peces de cultivo.
CL2020003168A1 (es) Métodos de uso de cd24 para prevenir y tratar la enfermedad de injerto contra huésped y la mucositis
AR111837A1 (es) Plantas transgénicas inmunomoduladoras y métodos relacionados
CL2017002931A1 (es) Método para incrementar la utilización de proteína de soja por peces salmónidos.
UY37979A (es) Sistema de cosecha subacuática mejorado
CL2018003037A1 (es) 2-alquilimidazolilcarboxamidas sustituidas como plaguicidas.
CL2021001689A1 (es) Ácido r-piridiloxicarboxílico y sal, derivado del éster, método de preparación, composición herbicida y aplicación del mismo.
ECSP20019404A (es) Agentes microbianos para alimentación directa para mejorar el estado general y salud de los peces
BR112021020349A2 (pt) Peixe estéril